Tourmaline Bio Inc. (TRML)
NASDAQ: TRML
· Real-Time Price · USD
18.11
-0.86 (-4.53%)
At close: Jun 17, 2025, 12:22 PM
-4.53% (1D)
| Bid | 18.07 |
| Market Cap | 465.22M |
| Revenue (ttm) | 40K |
| Net Income (ttm) | -82.87M |
| EPS (ttm) | -3.23 |
| PE Ratio (ttm) | -5.61 |
| Forward PE | -4.75 |
| Analyst | Buy |
| Ask | 18.14 |
| Volume | 48,856 |
| Avg. Volume (20D) | 348,709 |
| Open | 18.79 |
| Previous Close | 18.97 |
| Day's Range | 18.05 - 18.80 |
| 52-Week Range | 11.56 - 29.79 |
| Beta | 2.06 |
About TRML
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol TRML
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for TRML stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 weeks ago
-2.59%
TRML stock has given up its prior loss. Tourmaline...
Unlock content with
Pro Subscription
4 weeks ago
-2.59%
Tourmaline Bio shares are trading lower. The company announced topline results from its ongoing Phase 2 TRANQUILITY trial.
